Home LiteratureArticle Details
PMID: 7691712 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Extended haplotype analysis of cystic fibrosis mutations and its implications for the selective advantage hypothesis.

Human genetics ·Vol. 92 ·No. 3 ·1993-10-01 ·Pages 289-95

Sereth H, Shoshani T, Bashan N, Kerem BS

Abstract

The major cystic fibrosis (CF) mutation, delta F508, is associated with one haplotype (B) determined by the two polymorphic markers, XV2C and KM19. This haplotype is rare (15%) among non-CF chromosomes. Its frequency among non-delta F508 CF chromosomes is 50% with variation between populations. One hypothesis for the high frequency of CF haplotype B chromosomes suggests that there was a selective advantage for CF mutations on this specific "background" as a result of epistatic selection at other closely linked loci. Since the XV2C and KM19 markers are located 200 kb 5' to the CF gene and span only 60 kb, an extended haplotype analysis was needed to test this hypothesis. Haplotypes were determined for 183 CF and 120 non-CF Israeli chromosomes at the XV2C and KM19 loci and at three intragenic polymorphic sites (GATT in intron 6A, TUB18 in intron 19, and 24M in exon 24). Among the studied chromosomes the frequency of non-delta F508 CF chromosomes associated with haplotype B was 70% (88% among Ashkenazi CF chromosomes). Nine mutations (delta F508, W1282X, G542X, N1303K, 3849 + 10 kb C-->T, Q359K/T360K, S549I, S549R, and 1717-1G-->A) were identified among the studied chromosomes. These mutations accounted for 96% of CF chromosomes of Ashkenazi origin. Haplotype B was associated with seven of these (delta F508, W1282X, G542X, N1303K, Q359K/T360K, S549R, and 1717-1G-->A). The extended haplotype analysis revealed that in five of the seven mutations associated with the haplotype B, 97% of the chromosomes shared the same intragenic haplotype, 212. The variation found in 3% of the chromosomes was only in the GATT repeat. Two mutations, W1282X and 1717-1G-->A, were associated with a completely different intragenic haplotype, 121. The results of this study indicate that grouping of CF chromosome by haplotype analysis spanning a small extragenic region might not be sufficient. In addition, the results of the extended haplotype analysis indicate that all the studied CF chromosomes that carry the same mutation derived from the same origin. Furthermore, the results indicate that the majority of the CF mutations are associated with the same extended haplotype, supporting the selective advantage hypothesis.

MeSH Terms
Alleles Base Sequence Cystic Fibrosis/epidemiology,ethnology,genetics Cystic Fibrosis Transmembrane Conductance Regulator DNA Mutational Analysis DNA Primers Epistasis, Genetic Gene Frequency Genes, Lethal Haplotypes Humans Israel/epidemiology Jews/genetics Membrane Proteins/genetics Molecular Epidemiology Molecular Sequence Data Mutation Polymerase Chain Reaction Polymorphism, Restriction Fragment Length Selection, Genetic
Chemicals
CFTR protein, human DNA Primers Membrane Proteins Cystic Fibrosis Transmembrane Conductance Regulator
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Sereth H
Genetics Department, Hebrew University of Jerusalem, Israel.
Shoshani T
Bashan N
Kerem B S
References (26)
26 references, click to expand
  1. Identification of the cystic fibrosis gene: chromosome walking and jumping.
    Science. 1989 Sep 8;245(4922):1059-65 PMID: 2772657
  2. Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease.
    Am J Hum Genet. 1992 Jan;50(1):222-8 PMID: 1370365
  3. Ethnic variation in genetic disease: possible roles of hitchhiking and epistasis.
    Am J Hum Genet. 1975 May;27(3):348-64 PMID: 803016
  4. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.
    Science. 1989 Sep 8;245(4922):1066-73 PMID: 2475911
  5. The search for south European cystic fibrosis mutations: identification of two new mutations, four variants, and intronic sequences.
    Genomics. 1991 May;10(1):193-200 PMID: 2045102
  6. Three point mutations in the CFTR gene in French cystic fibrosis patients: identification by denaturing gradient gel electrophoresis.
    Hum Genet. 1990 Sep;85(4):446-9 PMID: 2210768
  7. Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
    Genomics. 1991 May;10(1):214-28 PMID: 1710598
  8. Rapid nonradioactive detection of the major cystic fibrosis mutation.
    Am J Hum Genet. 1990 Feb;46(2):395-6 PMID: 2301405
  9. Patterns of polymorphism and linkage disequilibrium for cystic fibrosis.
    Genomics. 1987 Nov;1(3):257-63 PMID: 2895728
  10. Approaches to localizing disease genes as applied to cystic fibrosis.
    Nucleic Acids Res. 1990 Jan 25;18(2):345-50 PMID: 1970161
  11. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.
    Science. 1985 Dec 20;230(4732):1350-4 PMID: 2999980
  12. A candidate for the cystic fibrosis locus isolated by selection for methylation-free islands.
    Nature. 1987 Apr 30-May 6;326(6116):840-5 PMID: 2883581
  13. Intra- and extragenic marker haplotypes of CFTR mutations in cystic fibrosis families.
    Hum Genet. 1992 Feb;88(4):417-25 PMID: 1371263
  14. Gradient of distribution in Europe of the major CF mutation and of its associated haplotype. European Working Group on CF Genetics (EWGCFG).
    Hum Genet. 1990 Sep;85(4):436-45 PMID: 2210767
  15. Isolation of additional polymorphic clones from the cystic fibrosis region, using chromosome jumping from D7S8.
    Am J Hum Genet. 1989 May;44(5):695-703 PMID: 2565081
  16. A mutation in the second nucleotide binding fold of the cystic fibrosis gene.
    Am J Hum Genet. 1991 Mar;48(3):608-12 PMID: 1998343
  17. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.
    Science. 1988 Jan 29;239(4839):487-91 PMID: 2448875
  18. A new mutation in the CFTR gene, composed of two adjacent DNA alterations, is a common cause of cystic fibrosis among Georgian Jews.
    Genomics. 1993 Jan;15(1):236-7 PMID: 7679367
  19. A dimorphic 4-bp repeat in the cystic fibrosis gene is in absolute linkage disequilibrium with the delta F508 mutation: implications for prenatal diagnosis and mutation origin.
    Am J Hum Genet. 1991 Feb;48(2):223-6 PMID: 1990833
  20. Identification of the cystic fibrosis gene: genetic analysis.
    Science. 1989 Sep 8;245(4922):1073-80 PMID: 2570460
  21. Why is the cystic fibrosis gene so frequent?
    Hum Genet. 1989 Dec;84(1):1-5 PMID: 2691388
  22. Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene.
    Proc Natl Acad Sci U S A. 1990 Nov;87(21):8447-51 PMID: 2236053
  23. A tetranucleotide repeat polymorphism in the cystic fibrosis gene.
    Hum Genet. 1991 Apr;86(6):625 PMID: 1709137
  24. The mutational specificity of DNA polymerase-beta during in vitro DNA synthesis. Production of frameshift, base substitution, and deletion mutations.
    J Biol Chem. 1985 May 10;260(9):5787-96 PMID: 3988773
  25. Mutations and sequence variations detected in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: a report from the Cystic Fibrosis Genetic Analysis Consortium.
    Hum Mutat. 1992;1(3):197-203 PMID: 1284534
  26. Detection of over 98% cystic fibrosis mutations in a Celtic population.
    Nat Genet. 1992 Jun;1(3):188-91 PMID: 1284639
Article Info
Journal
Human genetics
Abbr.
Hum Genet
ISSN
0340-6717
Published
1993-10-01
Pages
289-95
Language
English
Region
Germany
NLM ID
7613873
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com